RBM-004

N/A

Report date: 2023/05/22 10:19:12
NME

Base Information

Drug NameRBM-004
Drug Alias NameRBM-004
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionNerve growth factor inhibitors
TargetsNerve growth factor
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRibomic
China Registration ClassN/A

Develop Information

Active CompaniesFujimoto Pharmaceutical CorpRibomic
Inactive CompaniesN/A
Active IndicationsNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A